Kalaris Therapeutics Inc (KLRS)

09:27 AM

Kalaris Therapeutics Inc. (NASDAQ:KLRS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

09:27 AM

09:27 AM

Citizens Jmp Begins Coverage on Kalaris Therapeutics (NASDAQ:KLRS) - MarketBeat

09:27 AM

07:16 AM

What to expect from Kalaris Therapeutics Inc. in the next 30 daysLong Setup & Consistent Growth Stock Picks - newser.com

07:16 AM

07:02 AM

How resilient is Kalaris Therapeutics Inc. stock in market downturnsGap Up & High Accuracy Investment Entry Signals - newser.com

07:02 AM

06:56 AM

Does Kalaris Therapeutics Inc. qualify in momentum factor screeningWeekly Investment Report & Verified Stock Trade Ideas - newser.com

06:56 AM

05:27 AM

What MACD and RSI say about Kalaris Therapeutics Inc.Weekly Trend Recap & Daily Profit Maximizing Trade Tips - newser.com

05:27 AM

02:09 AM

Analyzing Kalaris Therapeutics Inc. with risk reward ratio chartsMarket Trend Report & Weekly Stock Breakout Alerts - newser.com

02:09 AM

12:21 PM

Kalaris Therapeutics Appoints Matthew Gall as Chief Financial Officer - VisionMonday.com

12:21 PM

Nov 03, 2025

Tools to assess Kalaris Therapeutics Inc.’s risk profile2025 EndofYear Setup & Weekly Market Pulse Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Identifying reversal signals in Kalaris Therapeutics Inc.Bull Run & Growth-Oriented Investment Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Citizens Initiates Coverage of Kalaris Therapeutics (KLRS) with Market Outperform Recommendation - Nasdaq

Nov 03, 2025

Nov 03, 2025

Kalaris Therapeutics appoints Matthew Gall as chief financial officer By Investing.com - Investing.com Nigeria

Nov 03, 2025

Nov 03, 2025

KLRS Sees New Analyst Rating: Citizens Initiates with Market Out - GuruFocus

Nov 03, 2025

Nov 03, 2025

Can trapped investors hope for a rebound in Kalaris Therapeutics Inc.Bull Run & Real-Time Chart Breakout Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Will Kalaris Therapeutics Inc. outperform the marketMarket Trend Summary & Risk Managed Investment Signals - newser.com

Nov 03, 2025

Nov 03, 2025

How Kalaris Therapeutics Inc. stock performs in rate cut cycles2025 Macro Impact & Step-by-Step Trade Execution Guides - newser.com

Nov 03, 2025

Nov 03, 2025

Kalaris Therapeutics Appoints New CFO Matthew Gall - TipRanks

Nov 03, 2025

Nov 03, 2025

Kalaris Therapeutics appoints Matthew Gall as chief financial officer - Investing.com

Nov 03, 2025

Nov 03, 2025

Kalaris Expands Leadership Team Appointing Matthew Gall, MBA, as Chief Financial Officer - The Manila Times

Nov 03, 2025

Nov 03, 2025

Kalaris (KLRS) names Matthew Gall CFO amid Phase 1b/2 nAMD study enrollment - Stock Titan

Nov 03, 2025

Nov 03, 2025

What’s next for Kalaris Therapeutics Inc. stock price2025 Short Interest & Target Return Focused Stock Picks - newser.com

Nov 03, 2025

Nov 03, 2025

Can Kalaris Therapeutics Inc. rally from current levelsJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Is Kalaris Therapeutics Inc. stock positioned for digital transformationQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com

Nov 03, 2025

Nov 03, 2025

Citizens initiates Kalaris stock with Market Outperform rating, $20 price target By Investing.com - Investing.com South Africa

Nov 03, 2025

Nov 03, 2025

Citizens initiates Kalaris stock with Market Outperform rating, $20 price target - Investing.com

Nov 03, 2025

Nov 02, 2025

Short Interest in Kalaris Therapeutics Inc. (NASDAQ:KLRS) Declines By 40.5% - MarketBeat

Nov 02, 2025

Oct 31, 2025

How to use a screener to detect Kalaris Therapeutics Inc. breakoutsJuly 2025 WrapUp & Weekly Watchlist of Top Performers - newser.com

Oct 31, 2025

Oct 31, 2025

Kalaris Therapeutics Inc. stock outlook for YEAR2025 Performance Recap & Community Verified Watchlist Alerts - newser.com

Oct 31, 2025